<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00924755</url>
  </required_header>
  <id_info>
    <org_study_id>BMX-2008-03</org_study_id>
    <nct_id>NCT00924755</nct_id>
  </id_info>
  <brief_title>Study of Surgical Mesh for Inguinal Hernia Repair</brief_title>
  <official_title>Early Outcome of Inguinal Hernia Repair With Biomerix Surgical Mesh Using the Lichtenstein Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomerix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomerix</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the early outcomes when using the Biomerix Revive™ as&#xD;
      a tension-free onlay patch, Lichtenstein-style, in patients who are candidates for primary,&#xD;
      unilateral, open inguinal hernia repair.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technical success with no complications through 6 weeks.</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hernia recurrence</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain and functional status</measure>
    <time_frame>10 day, 6 weeks, 6 months 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>10 days, 6 weeks, 6 months, 1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Hernia, Inguinal</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biomerix Revive™ (surgical mesh for inguinal hernia repair)</intervention_name>
    <description>Inguinal hernia repair using a tension-free onlay patch, Lichtenstein-style.</description>
    <other_name>Revive</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male ≥19 years old&#xD;
&#xD;
          -  symptomatic and palpable inguinal hernia&#xD;
&#xD;
          -  candidate for unilateral, primary, open inguinal hernia repair using the Lichtenstein&#xD;
             technique&#xD;
&#xD;
          -  will comply with required follow-up study visits&#xD;
&#xD;
          -  willing and able to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI ≥35&#xD;
&#xD;
          -  life expectancy of &lt;3 years&#xD;
&#xD;
          -  strangulated hernia&#xD;
&#xD;
          -  urologic disorder and/or previous urologic surgery in the testicular area (with the&#xD;
             exception of prostate surgery)&#xD;
&#xD;
          -  active abdominal surgical condition such as bowel obstruction or perforation&#xD;
&#xD;
          -  local or systemic infection or peritonitis&#xD;
&#xD;
          -  known disease that impairs wound healing&#xD;
&#xD;
          -  anti-platelet therapy (other than aspirin) for &gt;7 days preceding the surgical&#xD;
             procedure&#xD;
&#xD;
          -  previous ipsilateral groin incision&#xD;
&#xD;
          -  receiving immunosuppressive therapy and/or has undergone radiation therapy to the&#xD;
             affected groin area&#xD;
&#xD;
          -  uncontrolled insulin-dependent diabetic with Hgb1Ac greater than 8&#xD;
&#xD;
          -  advanced cirrhosis with Child-Turcott Class of C or higher&#xD;
&#xD;
          -  severe COPD requiring home oxygen&#xD;
&#xD;
          -  diagnosed with chronic pain syndrome or is undergoing treatment for pain management&#xD;
&#xD;
          -  candidate for another major surgical procedure with the inguinal hernia repair&#xD;
&#xD;
          -  enrolled in another investigational study that may confound the results of this study&#xD;
&#xD;
          -  known drug abuser&#xD;
&#xD;
          -  on anti-psychotic medications&#xD;
&#xD;
          -  Worker's Compensation case&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samir S Awad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Creighton University</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68178</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael E. DeBakey Veterans Affairs Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <study_first_submitted>June 17, 2009</study_first_submitted>
  <study_first_submitted_qc>June 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2009</study_first_posted>
  <last_update_submitted>October 1, 2010</last_update_submitted>
  <last_update_submitted_qc>October 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 4, 2010</last_update_posted>
  <responsible_party>
    <name_title>Christina Kichula</name_title>
    <organization>Biomerix</organization>
  </responsible_party>
  <keyword>Surgical mesh</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 20, 2017</submitted>
    <returned>April 28, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

